Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05410327 · ClinicalTrials.gov registry record · NA
Health Effects of Traditional Indigenous Chokeberry
A NA study, sponsored by University of North Dakota.
- Completed
- Registry status
- NA
- Development phase
- 46
- Enrollment target
NCT05410327: Completed NA study, sponsored by University of North Dakota.
NCT05410327 is a NA study that has completed, run by University of North Dakota. The registered enrollment target is 46 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05410327, a NA study, has completed, sponsored by University of North Dakota.
- COMPLETED
- Registry status
- NA
- Development phase
- 46 participants
- Enrollment target
Study Summary
American Indian populations continue to suffer disproportionately from health problems including such nutrition-related chronic diseases as diabetes and heart disease. This research project will therefore investigate how a traditional Indigenous food called chokeberry (Aronia melanocarpa) impacts epigenetic and metabolic health in relation to resiliency markers in American Indian participants. The process of research with American Indian communities is significant in that it can inform best practices in community engagement orientations, approaches, and models in future research settings.
Primary Outcome
The assessment of change in methylation targeted genes
Interventions
- OTHER Chokeberry (Aronia melanocarpa) juice
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2022-07-13 |
| Est. Completion | 2023-01-27 |
| Phase | NA |
What the finished NCT05410327 record still lists
NCT05410327 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 46 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which Chokeberry (Aronia melanocarpa) juice is the first listed.
NCT05410327 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05410327 about?
NCT05410327 is a clinical study titled "Health Effects of Traditional Indigenous Chokeberry". American Indian populations continue to suffer disproportionately from health problems including such nutrition-related chronic diseases as diabetes and heart disease. This research project will therefore investigate how a traditional Indigenous food called chokeberry (Aronia melanocarpa) impacts ep...
What is the current status of trial NCT05410327?
This trial is currently completed. It is a NA study. The enrollment target is 46 participants. The study started on 2022-07-13. Estimated completion is 2023-01-27.
What interventions are being tested in trial NCT05410327?
The interventions under investigation include: Chokeberry (Aronia melanocarpa) juice (OTHER).
Who is sponsoring clinical trial NCT05410327?
This trial is sponsored by University of North Dakota, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05410327's enrollment target sits among peer trials
46 1402nd of 2000 higher than 590 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01890590 · 46 participants · NA
A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma
- NCT03191149 · 46 participants · Phase 2
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
- NCT03510208 · 46 participants · Phase 1
Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
- NCT04048278 · 46 participants · Early Phase 1
Lidocaine Infusion in Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI